enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Tofacitinib - Wikipedia

    en.wikipedia.org/wiki/Tofacitinib

    [8] [9] [10] It is a janus kinase (JAK) inhibitor, [8] [9] discovered and developed by the National Institutes of Health and Pfizer. Common side effects include diarrhea, headache, and high blood pressure. [10] Serious side effects may include infections, cancer, and pulmonary embolism.

  3. Janus kinase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Janus_kinase_inhibitor

    A Janus kinase inhibitor, also known as JAK inhibitor or jakinib, [1] is a type of immune modulating medication, which inhibits the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway in lymphocytes.

  4. Oclacitinib - Wikipedia

    en.wikipedia.org/wiki/Oclacitinib

    Oclacitinib lacks the side effects that most JAK inhibitors have in humans; instead, side effects are infrequent, mild, and mostly self-limiting. [13] [14] [16] The most common side effects are gastrointestinal problems (vomiting, diarrhea, and appetite loss) and lethargy. The GI problems can sometimes be alleviated by giving oclacitinib with food.

  5. Abrocitinib - Wikipedia

    en.wikipedia.org/wiki/Abrocitinib

    It is a selective inhibitor of the enzyme janus kinase 1 (JAK1). [15] It inhibits JAK1 by 28 fold of selectivity over JAK2 and more than 340 fold of selectivity over JAK3. Two mechanisms are involved in atopic dermatitis, one involves epidermal barrier disruptions, and the other one is cutaneous inflammation due to the immune system over response.

  6. Pfizer (PFE) Dermatitis JAK Inhibitor NDA Review Gets Delayed

    www.aol.com/news/pfizer-pfe-dermatitis-jak...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Ruxolitinib - Wikipedia

    en.wikipedia.org/wiki/Ruxolitinib

    Ruxolitinib (sold under the brand names Jakafi and Jakavi among others, and as Opzelura in cream form) is a medication used for the treatment of intermediate or high-risk myelofibrosis, [6] a type of myeloproliferative neoplasm that affects the bone marrow; [11] [12] polycythemia vera, when there has been an inadequate response to or intolerance of hydroxyurea; [6] [13] and steroid-refractory ...

  8. Can JAK Inhibitors Challenge Biologics?

    www.aol.com/news/2013-02-20-can-jak-inhibitors...

    If JAK inhibitors can show similarly impressive results, gain approval, and make a splash, then these blockbuster biologics could have some real competition. While the future is promising that "if ...

  9. Ritlecitinib - Wikipedia

    en.wikipedia.org/wiki/Ritlecitinib

    Ritlecitinib is a kinase inhibitor which inhibits Janus kinase 3 and tyrosine kinase. [6] [9] [10] The most common side effects include headache, diarrhea, acne, rashes, eczema, fever, mouth ulcers, dizziness, shingles rash, and abnormal findings in some laboratory test results. [11]